TrialEuropean journal of pediatrics2024

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study.

Dunbar Ivy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.